OUR FIRM

Latest News

March 16, 2022

Guggenheim Healthcare Talks: Oncology Conference

At this year’s Oncology Conference, we provided clients with direct access to industry leadership teams in a complex and constantly evolving sector. More than 50 biotech and pharmaceutical companies participated in our Guggenheim Healthcare Talks.


This communication does not constitute and should not be construed as an offer or solicitation with respect to the purchase or sale of any security, loan or other financial instrument. This information is presented for informational purposes only and should not be considered a recommendation of any particular security, strategy or investment product, as investing advice of any kind, or as offering or providing any investment product or service. Guggenheim and/or its affiliates may have material relationships with the issuers of securities, loans and other financial instruments referred to herein and their affiliates. With respect to any position Guggenheim or its affiliates may hold, such interests may be different from or adverse to your interests. This communication is intended for the sole use of the person to whom it is addressed by the sender. This communication is not intended to be distributed to any prospective or actual investors and, accordingly, may not be shown or given to any person other than the recipient, and is not to be forwarded to any other person, copied or otherwise reproduced or distributed to any such person in any manner whatsoever. Copyright © 2022 by Guggenheim Securities, LLC, a FINRA registered broker-dealer. All rights reserved.